The implications of ABCC3 in cancer drug resistance: can we use it as a therapeutic target?
Ontology highlight
ABSTRACT: Drug resistance is one of the main causes of chemotherapy failure. Although several factors are involved in cancer drug resistant, the exporter pumps overexpression that mediates the drugs flow to outside the cells and reduces both the drugs intracellular concentration and effectiveness, has been one of the most important challenges. Overexpression of ABCC3, a member of the ABCC subfamily, has been strongly associated to the resistance to multiple drugs. ABCC3 has been found highly expressed in different types of cancers and is associated with poor prognosis and resistance to treatments. In this review, we summarize the molecular mechanisms involved in cancer drug resistance and discuss the current knowledge about the structure, function and role of ABCC3 in drug resistance, as well as, th
SUBMITTER: Ramirez-Cosmes A
PROVIDER: S-EPMC8493376 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
ACCESS DATA